Robeco Institutional Asset Management B.V. Sells 42,768 Shares of The Clorox Company (NYSE:CLX)

Robeco Institutional Asset Management B.V. decreased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 14.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 248,901 shares of the company's stock after selling 42,768 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.20% of Clorox worth $40,548,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Innealta Capital LLC bought a new stake in shares of Clorox during the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC increased its position in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after buying an additional 130 shares in the last quarter. First Foundation Advisors bought a new position in shares of Clorox in the first quarter worth about $31,000. Family Firm Inc. bought a new position in shares of Clorox during the 2nd quarter valued at approximately $31,000. Finally, Quarry LP increased its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of NYSE CLX traded up $0.28 during mid-day trading on Wednesday, hitting $162.70. 1,731,057 shares of the company's stock traded hands, compared to its average volume of 1,245,675. The company has a market capitalization of $20.14 billion, a P/E ratio of 56.69, a PEG ratio of 3.11 and a beta of 0.41. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company's 50-day moving average is $161.89 and its two-hundred day moving average is $146.58.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company's quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.49 earnings per share. On average, equities analysts anticipate that The Clorox Company will post 6.81 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date is Wednesday, October 23rd. Clorox's dividend payout ratio (DPR) is 170.03%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.57% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CLX. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. DA Davidson boosted their price objective on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday. BNP Paribas upgraded Clorox to a "strong sell" rating in a research report on Friday, September 6th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and boosted their price target for the stock from $155.00 to $170.00 in a report on Wednesday. Finally, JPMorgan Chase & Co. increased their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a report on Friday, October 11th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.